Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tezspire (tezepelumab) and Dupixent (dupilumab) are both injectable biologic medications used to treat asthma, but they belong to different medication classes. Tezspire is a thymic stromal lymphopoietin (TSLP) blocker, while Dupixent is an interleukin antagonist. Tezspire is specifically approved for severe asthma in people aged 12 and older, whereas Dupixent is approved for moderate-to-severe asthma in people aged 6 and older, as well as other conditions like eczema and eosinophilic esophagitis. Tezspire is typically injected once a month by a healthcare professional, while Dupixent is usually injected every 1 to 4 weeks, depending on the condition being treated. Both medications are available as pre-filled pens and syringes. Tezspire has a low risk of side effects but can cause joint and back pain, while Dupixent can cause injection site reactions and eye inflammation. Both medications can cause serious allergic reactions and are not used to treat asthma attacks.
Tezspire (tezepelumab)
Dupixent (dupilumab)
Tezspire (tezepelumab)
Dupixent (dupilumab)
Summary of Tezspire vs. Dupixent
Summary for TSLP blocker
Prescription only
Tezspire (tezepelumab or tezepelumab-ekko) is one of the available biologics for treating asthma. It's approved for people 12 years and older with severe asthma that's not controlled by other medications. Tezspire (tezepelumab) is an injection that's given under the skin once per month by a healthcare professional (HCP). There's also a prefilled pen for Tezspire (tezepelumab) that you can use at home after proper training from an HCP. Side effects aren't common but can include joint and back pain.
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.
Indications of Tezspire vs. Dupixent
Indications for
•Add-on maintenance treatment for severe asthma in people ages 12 years and older
Indications for
•Moderate-to-severe eczema - for people 6 months and older
•Moderate-to-severe asthma - add-on maintenance for people 6 years and older